Like virtually all age-related chronic diseases, late-onset Alzheimer's disease (AD) develops
over an extended preclinical period and is associated with modifiable lifestyle and …

Alzheimer's disease (AD) affects more than 5 million Americans, with substantial
consequences for individuals with AD, families, and society in terms of morbidity, mortality …

Over 55 million people globally are living with dementia and, by 2050, this number is
projected to increase to 131 million. This poses immeasurable challenges for patients and …

Empirical evidence suggests that a fair proportion of dementia cases are preventable, that
some preventive actions can be taken immediately, and others may soon be implemented …

Abstract Introduction Multidomain intervention for Alzheimer's disease (AD) risk reduction is
an emerging therapeutic paradigm. Methods Patients were prescribed individually tailored …

Dementia risk reduction is a global health and fiscal priority given the current lack of effective
treatments and the projected increased number of dementia cases due to population …

Alzheimer's disease (AD) represents an increasing worldwide healthcare epidemic.
Secondary preventive disease-modifying treatments under clinical development are …

Abstract Alzheimer's disease (AD), the leading cause of dementia, has reached epidemic
proportions, with major social, medical and economical burdens. With no currently available …

The role that genetics plays in the development of late-onset Alzheimer's disease (AD) has
been widely studied, with one study estimating genetics to account for more than 50% of the …

• We propose that a concerted effort be made to discover modifiable risk factors for dementia
and to exploit those already identified.• International collaboration is needed on largescale …